Flagellate erythema [2]

International Journal of Dermatology

Volumn 45, Issue 5, 2006, Pages 627-631

  Yamamoto, Toshiyuki ^a   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; PEPLEOMYCIN;

ADULT ONSET STILL DISEASE; ALOPECIA; CLINICAL PROTOCOL; DERMATITIS; DERMATOMYOSITIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EDEMA; ERYTHEMA; FLAGELLATE ERYTHEMA; GANGRENE; HIDRADENITIS; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; LETTER; LUNG FIBROSIS; LUNG TOXICITY; MALIGNANT NEOPLASTIC DISEASE; NAIL DISEASE; RAYNAUD PHENOMENON; AGARICALES; CHEMICALLY INDUCED DISORDER; PATHOLOGY;

AGARICALES; BLEOMYCIN; DERMATOMYOSITIS; ERYTHEMA; HUMANS; PEPLOMYCIN; STILL'S DISEASE, ADULT-ONSET;

EID: 33646180189     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02647.x     Document Type: Letter

References (56)

1. Umezawa H, Maeda K, Takeuchi T, et al. New antibiotics, bleomycin A and B. J Antibiot 1966; 19: 200-209.
2. Onuma T, Holland JF, Masuda H, et al. Microbiological assay of bleomycin: Inactivation, tissue distribution, and clearance. Cancer 1974; 22: 1230-1238.
3. Cohen IS, Mosher MB, O'Keefe EJ, et al. Cutaneous toxicity of bleomycin in therapy. Arch Dermatol 1973; 107: 553-555.
4. Dantzig PI. Immunosuppressive and cytotoxic drugs in dermatology. Arch Dermatol 1974; 110: 393-406.
5. Werner Y, Törnberg B. Cutaneous side effects of bleomycin therapy. Acta Dermato Venereol (Stockh) 1976; 56: 155-158.
6. Nixon DW, Pirozzi D, York RM. Dermatologic changes after systemic cancer therapy. Cutis 1981; 27: 181-194.
7. DeSpain JD. Dermatologic toxicity of chemotherapy. Semin Oncol 1992; 19: 501-507.
8. Remlinger KA. Cutaneous reactions to chemotherapy drugs. The art of consultation. Arch Dermatol 2003; 139: 77-81.
9. Blum B, Carter SK, Agre K. A clinical review of bleomycin: A new antineoplastic agent. Cancer 1973; 31: 903-914.
10. Fernandez-Obregon AC, Hogan KP, Bibro MK. Flagellate pigmentation for intrapleural bleomycin. J Am Acad Dermatol 1985; 13: 464-468.
11. Polla BS, Merot Y, Saurat JH, et al. Flagellate pigmentation from bleomycin. J Am Acad Dermatol 1986; 14: 690.
12. Guillet G, Guillet MH, de Meaux H, et al. Cutaneous pigmented stripes and bleomycin treatment. Arch Dermatol 1986; 122: 381-382.
13. Lindae ML, Hu CH, Nickoloff BJ. Pruritic erythematous linear plaques on the neck and back. Arch Dermatol 1987; 123: 393-398.
14. Rademaker M, Meyrick-Thomas RH, Lowe DG. Linear streaking due to bleomycin. Clin Exp Dermatol 1987; 12: 457-459.
15. Lazar AP, Lazar P. Streaky pigmentation in a patient with acquired immune deficincy syndrome. (AIDS). Cutis 1988; 42: 397-398.
16. Vignini M, Miori L, Brusamoliono E, et al. Linear streaking after bleomycin administration. Clin Exp Dermatol 1989; 14: 261.
17. Cortina P, Garrido JA, Tomas JF, et al. "Flagellate" erythema from bleomycin. Dermatologica 1990; 180: 106-109.
18. Miori L, Vignini M, Rabbiosi G. Flagellate dermatitis after bleomycin: A histological and immunohistochemical study. Am J Dermatopathol 1990; 12: 598-602.
19. Duhra P, Ilchyshyn A, Das RN. Bleomycin-induced flagellate erythema. Clin Exp Dermatol 1991; 16: 216-217.
20. Tsuji T, Sawabe M. Hyperpigmentation in striae distensae after bleomycin treatment. J Am Acad Dermatol 1993; 28: 503-505.
21. Mowad CM, Nguyen TV, Elenitsas R, et al. Bleomycin-induced flagellate dermatitis: A clinical and histopathological review. Br J Dermatol 1994; 131: 700-702.
22. Zaki I, Haslam P, Scerri L. Flagellate erythema after intraperitoneal bleomycin. Clin Exp Dermatol 1994; 19: 366-367.
23. Mullai N, Khokha N, Shimoto G. Bleomycin cutaneous toxicity. J Clin Oncol 1998; 16: 1625-1627.
24. Yamamoto T, Yokozeki H, Nishioka K. Dermal sclerosis in the lesional skin of "flagellate"erythema (scratch dermatitis) induced by bleomycin. Dermatology 1998; 297: 399-400.
25. Rubeiz NG, Salem Z, Dibbs R, et al. Bleomycin-induced urticarial flagellate drug hypersensitivity reaction. Int J Dermatol 1999; 38: 140-141.
26. Nigro MG, Hsu S. Bleomycin-induced flagellate pigmentation. Cutis 2001; 68: 285-286.
27. von Hilsheimer GE, Norton SA. Delayed bleomycin-induced hyperpigmentation and pressure on the skin. J Am Acad Dermatol 2002; 46: 642-643.
28. Abess A, Keel DM, Graham BS. Flagellate hyperpigmentation following intralesional bleomycin treatment of verruca plantaris. Arch Dermatol 2003; 139: 337-339.
29. Wright AL, Bleehen SS, Champion AE. Reticulate pigmentation due to bleomycin: Light- and electron-microscopic studies. Dermatologica 1990; 180: 255-257.
30. Yagoda A, Mukherji B, Young C, et al. Bleomycin, an anti-tumor antibiotic: Clinical experience in 274 patients. Ann Intern Med 1972; 77: 861-870.
31. Kukla LJ, McGuire WP. Heat-induced recall of bleomycin skin changes. Cancer 1982; 50: 2283-2284.
32. Braun J, Hahn GM. Enhanced cell killing by bleomycin and 43 °C hyperthermia and the inhibition of recovery from potentially lethal damage. Cancer Res 1975; 35: 2921-2927.
33. Perrot H, Ortonne JP. Hyperpigmentation after bleomycin therapy: Ultrastructural study. Arch Dermatol Res 1978; 261: 245-252.
34. Templeton SF, Solomon AR, Swerlick RA. Intradermal bleomycin injections into normal human skin: A histopathologic and immunopathologic study. Arch Dermatol 1994; 130: 577-583.
35. Finch WR, Rodnan GP, Buckingham RB, et al. Bleomycin-induced scleroderma. J Rheumatol 1980; 7: 651-659.
36. Kerr LD, Spiera H. Scleroderma in association with the use of bleomycin: a report of 3 cases. J Rheumatol 1992; 19: 294-296.
37. Kim K-H, Yoon T-J, Oh C-W, et al. A case of bleomycin-induced scleroderma. J Kor Med Sci 1996; 11: 454-456.
38. Passiu G, Cauli A, Atzeni F, et al. Bleomycin-induced scleroderma: Report of a case with a chronic course rather than the typical acute/ subacute self-limiting form. Clin Rheumatol 1999; 18: 422-424.
39. Mountz JD, Downs Minor MB, Turner R, et al. Bleomycin-induced cutaneous toxicity in the rat: Analysis of histopathology and ultrastructure compared with progressive systemic sclerosis (scleroderma). Br J Dermatol 1983; 108: 679-686.
40. Yamamoto T. Animal model of sclerotic skin induced by bleomycin: A clue to the pathogenesis of and therapy for scleroderma? Clin Immunol 2002; 102: 209-216.
41. Yamamoto T, Eckes B, Krieg T. Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin gene expression in human skin fibroblasts. Arch Dermatol Res 2000; 292: 566-561.
42. Yamamoto T, Katayama I, Nishioka K. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors. J Rheumatol 1999; 26: 609-615.
43. Shumer SM, O'Keefe EJ. Bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol 1983; 9: 91-96.
44. Araki Y, Tamura K, Seita M. Side effect of peplomycin. Gan Kagaku Rhoho 1986; 13: 2446-2450.
45. Dupre A, Viraben R, Bonafe JL, et al. Zebra-like dermatomyositis. Arch Dermatol 1981; 117: 63-64.
46. Watanabe T, Tsuchida T. "Flagellate" erythema in dermatomyositis. Dermatology 1995; 190: 230-231.
47. Ferrer M, Herranz P, Manzano R, et al. Dermatomyositis with linear lesions. Br J Dermatol 1996; 134: 600-601.
48. Jara M, Amerigo J, Duce S, et al. Dermatomyositis and flagellate erythema. Clin Exp Dermatol 1997; 21: 440-441.
49. Nousari HC, Ha VT, Laman SD, et al. "Central flagellate erythema": A cutaneous manifestation associated with dermatomyositis. J Rheumatol 1999; 26: 692-695.
50. Centeno PG, Sanchez-Aguilar D, Pereiro M Jr, et al. Flagellate erythema and dermatomyositis. Clin Exp Dermatol 1998; 23: 239-240.
51. Shirani Z, Kucenic MJ, Carroll CL, et al. Pruritus in adult dermatomyositis. Clin Exp Dermatol 2004; 29: 273-276.
52. Suzuki K, Kimura Y, Aoki M, et al. Persistent plaques and linear pigmentation in adult-onset Still's disease. Dermatology 2001; 202: 333-335.
53. Fujii K, Konishi K, Kanno Y, et al. Persistent generalized erythema in adult-onset Still's disease. Int J Dermatol 2003; 42: 824-825.
54. Nakamura T. Shiitake (Lentinus edodes) dermatitis. Contact Dermatitis 1992; 27: 65-70.
55. Ohashi A, Ishida T, Tamaki A. Two cases of Shiitake dermatitis caused by dry shiitake. Rinsho Derma (Tokyo) 1991; 33: 1348-1349 (in Japanese).
56. Hanada K, Hashimoto I. Flagellate mushroom (shiitake) dermatitis and photosensitivity. Dermatology 1998; 197: 255-257.